Anti-obesity effect of Neoagaro-oligosaccharides with overweight and obese subjects: a 16-week, randomized, double-blind, placebo-controlled clinical trial.

Background: This trial aimed to evaluate the anti-obesity effects and safety of Neoagaro-oligosaccharides (NAOs) in humans in a 16 week, randomized, double-blind, placebo-controlled clinical trial. Methods: One hundred overweight or obese subjects with a body mass index of 23 to 34.9 kg/m2 and a per...

Full description

Bibliographic Details

Published in:	BMC Complementary Medicine & Therapies Vol. 23; no. 1; pp. 1 - 14
Main Authors:	Baek, Hyang-Im, Ha, Ki-Chan, Park, Yu Kyung, Lee, Je Hyeon, Kim, Eun Joo, Ko, Hye-Jeong, Joo, Jong Cheon
Format:	diagnostic images research tables/charts randomized controlled trial Journal Article
Published:	BioMed Central 10/19/2023
Online Access:	View this record in EBSCOhost